366 related articles for article (PubMed ID: 15624346)
1. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
2. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
3. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
4. Ephedra in perspective--a current review.
Abourashed EA; El-Alfy AT; Khan IA; Walker L
Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
[TBL] [Abstract][Full Text] [Related]
5. FDA to ban sales of dietary supplements containing ephedra.
Ling AM
J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
[No Abstract] [Full Text] [Related]
6. Beyond ephedra. Why the FDA's ban may lead users to look for other weight-loss stimulants.
Gupta S
Time; 2004 Jan; 163(2):78. PubMed ID: 14735657
[No Abstract] [Full Text] [Related]
7. Regarding the cardiovascular effects of an herbal ephedra-caffeine weight loss product.
Rawson ES; Persky AM
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1353-4. PubMed ID: 15052276
[No Abstract] [Full Text] [Related]
8. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
Kalman DS
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1355-6. PubMed ID: 15365583
[No Abstract] [Full Text] [Related]
9. Dietary supplements in weight reduction.
Dwyer JT; Allison DB; Coates PM
J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S80-6. PubMed ID: 15867902
[TBL] [Abstract][Full Text] [Related]
10. Addressing the potential risks associated with ephedra use: a review of recent efforts.
Schulman S
Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic agents for weight reduction.
Haller C; Schwartz JB
J Gend Specif Med; 2002; 5(5):16-21. PubMed ID: 12380196
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the stimulant content of dietary supplements marketed as "ephedra-free".
Gregory PJ
J Herb Pharmacother; 2007; 7(1):65-72. PubMed ID: 17594988
[TBL] [Abstract][Full Text] [Related]
13. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
Sharpe PA; Granner ML; Conway JM; Ainsworth BE; Dobre M
J Am Diet Assoc; 2006 Dec; 106(12):2045-51. PubMed ID: 17126636
[TBL] [Abstract][Full Text] [Related]
14. Adverse events of herbal food supplements for body weight reduction: systematic review.
Pittler MH; Schmidt K; Ernst E
Obes Rev; 2005 May; 6(2):93-111. PubMed ID: 15836459
[TBL] [Abstract][Full Text] [Related]
15. Ephedra: heart dangers in disguise.
Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
[No Abstract] [Full Text] [Related]
16. HHS to study ephedra, step up enforcement against illegal marketing.
FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
[No Abstract] [Full Text] [Related]
17. Ephedra ban: no shortage of reasons.
Rados C
FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
[TBL] [Abstract][Full Text] [Related]
18. Ephedra: once a boon, now a bane.
Scheindlin S
Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
[No Abstract] [Full Text] [Related]
19. Working to get ephedra banned.
Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
[No Abstract] [Full Text] [Related]
20. Ergogenic aids: an update on ephedra.
Keisler BD; Hosey RG
Curr Sports Med Rep; 2005 Aug; 4(4):231-5. PubMed ID: 16004835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
